Skip to main content
Top
Published in: Discover Oncology 2/2011

01-04-2011

Aberrant Activation of Cell Cycle Regulators, Centrosome Amplification, and Mitotic Defects

Author: Kenji Fukasawa

Published in: Discover Oncology | Issue 2/2011

Login to get access

Abstract

The centrosome that functions as a microtubule organizing center of a cell plays a key role in formation of bipolar mitotic spindles. Cells normally have either one (unduplicated) or two (duplicated) centrosomes. However, loss of the mechanisms controlling the numeral integrity of centrosomes leads to centrosome amplification (presence of more than two centrosomes), primarily via overduplication or fragmentation of centrosomes, resulting in defective mitosis and consequentially chromosome instability. Centrosome amplification frequently occurs in various cancers, and is considered as a major cause of chromosome instability. It has recently been found that ROCK2 kinase plays a critical role in promotion of centrosome duplication and amplification. Considering that ROCK2 is activated by Rho protein, and Rho is the immediate downstream target of many growth and hormone receptors, it is possible that such receptors may rather directly affect centrosome duplication and amplification. Indeed, constitutive activation of the receptors known to signal to the Rho pathway leads to promotion of centrosome amplification and chromosome instability in the Rho-ROCK2 pathway-dependent manner. These observations reveal an unexplored, yet important, oncogenic activities of those receptors in carcinogenesis; destabilizing chromosomes through promotion of centrosome amplification via continual activation of the Rho-ROCK2 pathway.
Literature
1.
2.
go back to reference Doxsey S (2002) Re-evaluating centrosome function. Nat Rev Mol Cell Biol 2:688–698CrossRef Doxsey S (2002) Re-evaluating centrosome function. Nat Rev Mol Cell Biol 2:688–698CrossRef
3.
go back to reference Fukasawa K (2005) Centrosome amplification, chromosome instability and cancer development. Cancer Lett 230:6–19PubMedCrossRef Fukasawa K (2005) Centrosome amplification, chromosome instability and cancer development. Cancer Lett 230:6–19PubMedCrossRef
4.
5.
go back to reference Brinkley BR (2001) Managing the centrosome numbers game: from chaos to stability in cancer cell division. Trends Cell Biol 11:18–21PubMedCrossRef Brinkley BR (2001) Managing the centrosome numbers game: from chaos to stability in cancer cell division. Trends Cell Biol 11:18–21PubMedCrossRef
6.
go back to reference D'Assoro AB, Lingle WL, Salisbury JL (2002) Centrosome amplification and the development of cancer. Oncogene 21:6146–6153PubMedCrossRef D'Assoro AB, Lingle WL, Salisbury JL (2002) Centrosome amplification and the development of cancer. Oncogene 21:6146–6153PubMedCrossRef
7.
go back to reference Ganem NJ, Godinho SA, Pellman D (2009) A mechanism linking extra centrosomes to chromosomal instability. Nature 460:278–282PubMedCrossRef Ganem NJ, Godinho SA, Pellman D (2009) A mechanism linking extra centrosomes to chromosomal instability. Nature 460:278–282PubMedCrossRef
8.
go back to reference Ma Z, Kanai M, Kawamura K et al (2006) Interaction between ROCK II and nucleophosmin/B23 in the regulation of centrosome duplication. Mol Cell Biol 26:9016–9034PubMedCrossRef Ma Z, Kanai M, Kawamura K et al (2006) Interaction between ROCK II and nucleophosmin/B23 in the regulation of centrosome duplication. Mol Cell Biol 26:9016–9034PubMedCrossRef
9.
go back to reference Hinchcliffe EH, Sluder G (2001) It takes two to tango: understanding how centrosome duplication is regulated throughout the cell cycle. Genes Dev 15:1167–1181PubMedCrossRef Hinchcliffe EH, Sluder G (2001) It takes two to tango: understanding how centrosome duplication is regulated throughout the cell cycle. Genes Dev 15:1167–1181PubMedCrossRef
10.
go back to reference Nevins JR (1992) E2F: a link between the Rb tumor suppressor protein and viral oncoproteins. Science 258:424–429PubMedCrossRef Nevins JR (1992) E2F: a link between the Rb tumor suppressor protein and viral oncoproteins. Science 258:424–429PubMedCrossRef
11.
go back to reference Hinchcliffe EH, Li C, Thompson EA et al (1999) Requirement of Cdk2-cyclin E activity for repeated centrosome reproduction in Xenopus egg extracts. Science 283:851–854PubMedCrossRef Hinchcliffe EH, Li C, Thompson EA et al (1999) Requirement of Cdk2-cyclin E activity for repeated centrosome reproduction in Xenopus egg extracts. Science 283:851–854PubMedCrossRef
12.
go back to reference Lacey KR, Jackson PK, Stearns T (1999) Cyclin-dependent kinase control of centrosome duplication. Proc Natl Acad Sci USA 96:2817–2822PubMedCrossRef Lacey KR, Jackson PK, Stearns T (1999) Cyclin-dependent kinase control of centrosome duplication. Proc Natl Acad Sci USA 96:2817–2822PubMedCrossRef
13.
go back to reference Matsumoto Y, Hayashi K, Nishida E (1999) Cyclin-dependent kinase 2 (Cdk2) is required for centrosome duplication in mammalian cells. Curr Biol 9:429–432PubMedCrossRef Matsumoto Y, Hayashi K, Nishida E (1999) Cyclin-dependent kinase 2 (Cdk2) is required for centrosome duplication in mammalian cells. Curr Biol 9:429–432PubMedCrossRef
14.
go back to reference Tarapore P, Okuda M, Fukasawa K (2002) A mammalian in vitro centriole duplication system: evidence for involvement of CDK2/cyclin E and Nucleophosmin/B23 in centrosome duplication. Cell Cycle 1:75–81PubMedCrossRef Tarapore P, Okuda M, Fukasawa K (2002) A mammalian in vitro centriole duplication system: evidence for involvement of CDK2/cyclin E and Nucleophosmin/B23 in centrosome duplication. Cell Cycle 1:75–81PubMedCrossRef
15.
17.
go back to reference Sancar A, Lindsey-Boltz LA, Unsal-Kacmaz K et al (2004) Molecular mechanisms of mammalian DNA repair and the DNA damage checkpoints. Annu Rev Biochem 73:39–85PubMedCrossRef Sancar A, Lindsey-Boltz LA, Unsal-Kacmaz K et al (2004) Molecular mechanisms of mammalian DNA repair and the DNA damage checkpoints. Annu Rev Biochem 73:39–85PubMedCrossRef
18.
go back to reference Harper JW (1997) Cyclin dependent kinase inhibitors. Cancer Surv 29:91–107PubMed Harper JW (1997) Cyclin dependent kinase inhibitors. Cancer Surv 29:91–107PubMed
19.
go back to reference Kawamura K, Izumi H, Ma Z et al (2004) Induction of centrosome amplification and chromosome instability in human bladder cancer cells by p53 mutation and cyclin E overexpression. Cancer Res 64:4800–4809PubMedCrossRef Kawamura K, Izumi H, Ma Z et al (2004) Induction of centrosome amplification and chromosome instability in human bladder cancer cells by p53 mutation and cyclin E overexpression. Cancer Res 64:4800–4809PubMedCrossRef
20.
go back to reference D'Assoro AB, Lingle WL, Salisbury JL (2004) Centrosome amplification and the origin of chromosomal instability in breast cancer. Mammary Gland Biol Neoplasia 9:275–283CrossRef D'Assoro AB, Lingle WL, Salisbury JL (2004) Centrosome amplification and the origin of chromosomal instability in breast cancer. Mammary Gland Biol Neoplasia 9:275–283CrossRef
21.
go back to reference Koutsami MK, Tsantoulis PK, Kouloukoussa M et al (2006) Centrosome abnormalities are frequently observed in non-small-cell lung cancer and are associated with aneuploidy and cyclin E overexpression. J Pathol 209:512–521PubMedCrossRef Koutsami MK, Tsantoulis PK, Kouloukoussa M et al (2006) Centrosome abnormalities are frequently observed in non-small-cell lung cancer and are associated with aneuploidy and cyclin E overexpression. J Pathol 209:512–521PubMedCrossRef
22.
go back to reference Weber RG, Bridger JM, Benner A et al (1998) Centrosome amplification as a possible mechanism for numerical chromosome aberrations in cerebral primitive neuroectodermal tumors with TP53 mutations. Cytogenet Cell Genet 83:266–269PubMedCrossRef Weber RG, Bridger JM, Benner A et al (1998) Centrosome amplification as a possible mechanism for numerical chromosome aberrations in cerebral primitive neuroectodermal tumors with TP53 mutations. Cytogenet Cell Genet 83:266–269PubMedCrossRef
23.
go back to reference Carroll PE, Okuda M, Horn HF et al (1999) Centrosome hyperamplification in human cancer: chromosome instability induced by p53 mutation and/or Mdm2 overexpression. Oncogene 18:1935–1944PubMedCrossRef Carroll PE, Okuda M, Horn HF et al (1999) Centrosome hyperamplification in human cancer: chromosome instability induced by p53 mutation and/or Mdm2 overexpression. Oncogene 18:1935–1944PubMedCrossRef
24.
go back to reference Pihan GA, Wallace J, Zhou Y et al (2003) Centrosome abnormalities and chromosome instability occur together in pre-invasive carcinomas. Cancer Res 63:1398–1404PubMed Pihan GA, Wallace J, Zhou Y et al (2003) Centrosome abnormalities and chromosome instability occur together in pre-invasive carcinomas. Cancer Res 63:1398–1404PubMed
25.
go back to reference Nakajima T, Moriguchi M, Mitsumoto Y et al (2004) Centrosome aberration accompanied with p53 mutation can induce genetic instability in hepatocellular carcinoma. Mod Pathol 17:722–727PubMedCrossRef Nakajima T, Moriguchi M, Mitsumoto Y et al (2004) Centrosome aberration accompanied with p53 mutation can induce genetic instability in hepatocellular carcinoma. Mod Pathol 17:722–727PubMedCrossRef
26.
go back to reference Mussman JG, Horn HF, Carroll PE et al (2000) Synergistic induction of centrosome hyperamplification by loss of p53 and cyclin E overexpression. Oncogene 19:1635–1646PubMedCrossRef Mussman JG, Horn HF, Carroll PE et al (2000) Synergistic induction of centrosome hyperamplification by loss of p53 and cyclin E overexpression. Oncogene 19:1635–1646PubMedCrossRef
27.
go back to reference Okuda M, Horn HF, Tarapore P et al (2000) Nucleophosmin/B23 is a target of CDK2-cyclin E in centrosome duplication. Cell 103:127–140PubMedCrossRef Okuda M, Horn HF, Tarapore P et al (2000) Nucleophosmin/B23 is a target of CDK2-cyclin E in centrosome duplication. Cell 103:127–140PubMedCrossRef
28.
go back to reference Fisk HA, Winey A (2001) The mouse Mps1p-like kinase regulates centrosome duplication. Cell 106:95–104PubMedCrossRef Fisk HA, Winey A (2001) The mouse Mps1p-like kinase regulates centrosome duplication. Cell 106:95–104PubMedCrossRef
29.
go back to reference Chen Z, Indjeian VB, McManus M et al (2002) CP110, a cell cycle-dependent CDK substrate, regulates centrosome duplication in human cells. Dev Cell 3:339–350PubMedCrossRef Chen Z, Indjeian VB, McManus M et al (2002) CP110, a cell cycle-dependent CDK substrate, regulates centrosome duplication in human cells. Dev Cell 3:339–350PubMedCrossRef
30.
go back to reference Szebeni A, Olson MO (1999) Nucleolar protein B23 has molecular chaperone activities. Protein Sci 8:905–912PubMedCrossRef Szebeni A, Olson MO (1999) Nucleolar protein B23 has molecular chaperone activities. Protein Sci 8:905–912PubMedCrossRef
31.
go back to reference Takemura M, Sato K, Nishio M et al (1999) Nucleolar protein B23.1 binds to retinoblastoma protein and synergistically stimulates DNA polymerase alpha activity. J Biochem 125:904–909PubMed Takemura M, Sato K, Nishio M et al (1999) Nucleolar protein B23.1 binds to retinoblastoma protein and synergistically stimulates DNA polymerase alpha activity. J Biochem 125:904–909PubMed
32.
go back to reference Valdez BC, Perlaky L, Henning D et al (1994) Identification of the nuclear and nucleolar localization signals of the protein p120. Interaction with translocation protein B23. J Biol Chem 269:23776–23783PubMed Valdez BC, Perlaky L, Henning D et al (1994) Identification of the nuclear and nucleolar localization signals of the protein p120. Interaction with translocation protein B23. J Biol Chem 269:23776–23783PubMed
33.
go back to reference Tarapore P, Shinmura K, Suzuki H et al (2006) Thr199 phosphorylation targets nucleophosmin to nuclear speckles and represses pre-mRNA processing. FEBS Lett 580:399–409PubMedCrossRef Tarapore P, Shinmura K, Suzuki H et al (2006) Thr199 phosphorylation targets nucleophosmin to nuclear speckles and represses pre-mRNA processing. FEBS Lett 580:399–409PubMedCrossRef
34.
go back to reference Colombo E, Marine JC, Danovi D et al (2002) Nucleophosmin regulates the stability and transcriptional activity of p53. Nat Cell Biol 4:529–533PubMedCrossRef Colombo E, Marine JC, Danovi D et al (2002) Nucleophosmin regulates the stability and transcriptional activity of p53. Nat Cell Biol 4:529–533PubMedCrossRef
35.
go back to reference Bertwistle D, Sugimoto M, Sherr CJ (2004) Physical and functional interactions of the Arf tumor suppressor protein with Nucleophosmin/B23. Mol Cell Biol 24:985–996PubMedCrossRef Bertwistle D, Sugimoto M, Sherr CJ (2004) Physical and functional interactions of the Arf tumor suppressor protein with Nucleophosmin/B23. Mol Cell Biol 24:985–996PubMedCrossRef
36.
go back to reference Korgaonkar C, Hagen J, Tompkins V et al (2005) Nucleophosmin (B23) targets ARF to nucleoli and inhibits its function. Mol Cell Biol 25:1258–1271PubMedCrossRef Korgaonkar C, Hagen J, Tompkins V et al (2005) Nucleophosmin (B23) targets ARF to nucleoli and inhibits its function. Mol Cell Biol 25:1258–1271PubMedCrossRef
37.
go back to reference Tokuyama Y, Horn HF, Kawamura K et al (2001) Specific phosphorylation of nucleophosmin on Thr(199) by cyclin-dependent kinase 2-cyclin E and its role in centrosome duplication. J Biol Chem 276:21529–21537PubMedCrossRef Tokuyama Y, Horn HF, Kawamura K et al (2001) Specific phosphorylation of nucleophosmin on Thr(199) by cyclin-dependent kinase 2-cyclin E and its role in centrosome duplication. J Biol Chem 276:21529–21537PubMedCrossRef
38.
go back to reference Grisendi S, Bernardi R, Rossi M et al (2005) Role of Nucleophosmin in embryonic development and tumorigenesis. Nature 437:147–153PubMedCrossRef Grisendi S, Bernardi R, Rossi M et al (2005) Role of Nucleophosmin in embryonic development and tumorigenesis. Nature 437:147–153PubMedCrossRef
39.
go back to reference Leung T, Chen XQ, Manser E et al (1996) The p160 RhoA-binding kinase ROK alpha is a member of a kinase family and is involved in the reorganization of the cytoskeleton. Mol Cell Biol 16:5313–5327PubMed Leung T, Chen XQ, Manser E et al (1996) The p160 RhoA-binding kinase ROK alpha is a member of a kinase family and is involved in the reorganization of the cytoskeleton. Mol Cell Biol 16:5313–5327PubMed
40.
go back to reference Matsui T, Amano M, Yamamoto T et al (1996) Rho-associated kinase, a novel serine/threonine kinase, as a putative target for small GTP binding protein Rho. EMBO J 15:2208–2216PubMed Matsui T, Amano M, Yamamoto T et al (1996) Rho-associated kinase, a novel serine/threonine kinase, as a putative target for small GTP binding protein Rho. EMBO J 15:2208–2216PubMed
41.
go back to reference Nakagawa O, Fujisawa K, Ishizaki T et al (1996) ROCK-I and ROCK-II, two isoforms of Rho-associated coiled-coil forming protein serine/threonine kinase in mice. FEBS Lett 392:189–193PubMedCrossRef Nakagawa O, Fujisawa K, Ishizaki T et al (1996) ROCK-I and ROCK-II, two isoforms of Rho-associated coiled-coil forming protein serine/threonine kinase in mice. FEBS Lett 392:189–193PubMedCrossRef
42.
go back to reference Etienne-Manneville S, Hall A (2002) Rho GTPases in cell biology. Nature 420:692–695CrossRef Etienne-Manneville S, Hall A (2002) Rho GTPases in cell biology. Nature 420:692–695CrossRef
43.
go back to reference Amano M, Ito M, Kimura K et al (1996) Phosphorylation and activation of myosin by Rho-associated kinase (Rho-kinase). J Biol Chem 271:20246–20249PubMedCrossRef Amano M, Ito M, Kimura K et al (1996) Phosphorylation and activation of myosin by Rho-associated kinase (Rho-kinase). J Biol Chem 271:20246–20249PubMedCrossRef
44.
go back to reference Wheeler AP, Ridley AJ (2004) Why three Rho proteins? RhoA, RhoB, RhoC, and cell motility. Exp Cell Res 301:43–49PubMedCrossRef Wheeler AP, Ridley AJ (2004) Why three Rho proteins? RhoA, RhoB, RhoC, and cell motility. Exp Cell Res 301:43–49PubMedCrossRef
45.
go back to reference Kanai M, Crowe MS, Zheng Y et al (2010) RhoA and RhoC are both required for the ROCK II-dependent promotion of centrosome duplication. Oncogene 29(45):6040–6050PubMedCrossRef Kanai M, Crowe MS, Zheng Y et al (2010) RhoA and RhoC are both required for the ROCK II-dependent promotion of centrosome duplication. Oncogene 29(45):6040–6050PubMedCrossRef
46.
go back to reference Fujisawa K, Madaule P, Ishizaki T et al (1998) Different regions of Rho determine Rho-selective binding of different classes of Rho target molecules. J Biol Chem 273:18943–18949PubMedCrossRef Fujisawa K, Madaule P, Ishizaki T et al (1998) Different regions of Rho determine Rho-selective binding of different classes of Rho target molecules. J Biol Chem 273:18943–18949PubMedCrossRef
47.
go back to reference Sahai E, Alberts AS, Treisman R (1998) RhoA effector mutants reveal distinct effector pathways for cytoskeletal reorganization, SRF activation and transformation. EMBO J 17:1350–1361PubMedCrossRef Sahai E, Alberts AS, Treisman R (1998) RhoA effector mutants reveal distinct effector pathways for cytoskeletal reorganization, SRF activation and transformation. EMBO J 17:1350–1361PubMedCrossRef
49.
go back to reference Schiller MR (2006) Coupling receptor tyrosine kinases to Rho GTPases–GEFs what's the link. Cell Signal 18:1834–1843PubMedCrossRef Schiller MR (2006) Coupling receptor tyrosine kinases to Rho GTPases–GEFs what's the link. Cell Signal 18:1834–1843PubMedCrossRef
50.
go back to reference Sherline P, Mascardo RN (1982) Epidermal growth factor induces rapid centrosomal separation in HeLa and 3T3 cells. J Cell Biol 93:507–511PubMedCrossRef Sherline P, Mascardo RN (1982) Epidermal growth factor induces rapid centrosomal separation in HeLa and 3T3 cells. J Cell Biol 93:507–511PubMedCrossRef
51.
go back to reference Balczon R, Bao L, Zimmer WE et al (1995) Dissociation of centrosome replication events from cycles of DNA synthesis and mitotic division in hydroxyurea-arrested Chinese hamster ovary cells. J Cell Biol 130:105–115PubMedCrossRef Balczon R, Bao L, Zimmer WE et al (1995) Dissociation of centrosome replication events from cycles of DNA synthesis and mitotic division in hydroxyurea-arrested Chinese hamster ovary cells. J Cell Biol 130:105–115PubMedCrossRef
52.
go back to reference Shinomiya N, Gao CF, Xie Q, Gustafson M, Waters DJ, Zhang YW, Vande Woude GF (2004) RNA interference reveals that ligand-independent met activity is required for tumor cell signaling and survival. Cancer Res 64:7962–7970PubMedCrossRef Shinomiya N, Gao CF, Xie Q, Gustafson M, Waters DJ, Zhang YW, Vande Woude GF (2004) RNA interference reveals that ligand-independent met activity is required for tumor cell signaling and survival. Cancer Res 64:7962–7970PubMedCrossRef
Metadata
Title
Aberrant Activation of Cell Cycle Regulators, Centrosome Amplification, and Mitotic Defects
Author
Kenji Fukasawa
Publication date
01-04-2011
Publisher
Springer-Verlag
Published in
Discover Oncology / Issue 2/2011
Print ISSN: 1868-8497
Electronic ISSN: 2730-6011
DOI
https://doi.org/10.1007/s12672-010-0060-4

Other articles of this Issue 2/2011

Discover Oncology 2/2011 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine